Lappe-Siefke, C.; Goebbels, S.; Gravel, M.; Nicksch, E.; Lee, J.; Braun, P. E.; Griffiths, I. R.; Nave, K.-A.: Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nature Genetics 33 (3), S. 366 - 374 (2003)

Matthias, K.; Kirchhoff, F.; Seifert, G.; Hüttmann, K.; Matyash, M.; Kettenmann, H.; Steinhäuser, C.: Segregated expression of AMPA-type glutamate receptors and glutamate transporters defines distinct astrocyte populations in the mouse hippocampus. The Journal of Neuroscience 23 (5), S. 1750 - 1758 (2003)

Radulovic, M.; Hippel, C.; Spiess, J.: Corticotropin-releasing factor (CRF) rapidly suppresses apoptosis by acting upstream of the activation of caspases. Journal of Neurochemistry: official journal of the International Society for Neurochemistry 84 (5), S. 1074 - 1085 (2003)

Fischer, A.; Sananbenesi, F.; Schrick, C.; Spiess, J.; Radulovic, J.: Regulation of contextual fear conditioning by baseline and inducible septo-hippocampal cyclin-dependent kinase 5. Neuropharmacology 44, S. 1089 - 1099 (2003)

Stegmüller, J.; Werner, H.; Nave, K.-A.; Trotter, J.: The proteoglycan NG2 is complexed with α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells - Implications for glial-neuronal signaling. The Journal of Biological Chemistry 278 (6), S. 3590 - 3598 (2003)

Erb, M.; Steck, A. J.; Nave, K.-A.; Schaeren-Wiemers, N.: Differential expression of L- and S-MAG upon cAMP stimulated differentiation in oligodendroglial cells. Journal of Neuroscience Research 71 (3), S. 326 - 337 (2003)

Kriegstein, K.; Schmitz, F.: The expression pattern and assembly profile of synaptic membrane proteins in ribbon synapses of the developing mouse retina. Cell and Tissue Research 311 (2), S. 159 - 173 (2003)

Misane, I.; Ögren, S. O.: Selective 5-HT1A antagonists WAY 100635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat. Neuropsychopharmacology 28 (2), S. 253 - 264 (2003)

Stiedl, O.; Meyer, M.: Cardiac dynamics in corticotropin-releasing factor receptor subtype-2 deficient mice. Neuropeptides 37 (1), S. 3 - 16 (2003)

Ferber, M.; Sporning, A.; Jeserich, G.; DeLaCruz, R.; Watkins, M.; Olivera, B. M.; Terlau, H.: A novel Conus peptide ligand for K+ channels. The Journal of Biological Chemistry 278 (4), S. 2177 - 2183 (2003)

Blank, T.; Nijholt, I.; Vollstaedt, S.; Spiess, J.: The corticotropin-releasing factor receptor 1 antagonist CP- 154,526 reverses stress-induced learning deficits in mice. Behavioural Brain Research 138 (2), S. 207 - 213 (2003)

Blank, T.; Nijholt, I.; Grammatopoulos, D. K.; Randeva, H. S.; Hillhouse, E. W.; Spiess, J.: Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: Role in neuronal excitability and associative learning. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 23 (2), S. 700 - 707 (2003)

Soto, F.; Krause, U.; Borchardt, K.; Ruppelt, A.: Cloning, tissue distribution and functional characterization of the chicken P2X(1) receptor. FEBS Letters 533 (1-3), S. 54 - 58 (2003)

Becherer, U.; Moser, T.; Stühmer, W.; Oheim, M.: Calcium regulates exocytosis at the level of single vesicles. Nature Neuroscience 6 (8), S. 846 - 853 (2003)

Carneiro, C. M.M.; Merzlyak, P. G.; Yuldasheva, L. N.; Silva, L. G.; Thinnes, F. P.; Krasilnikov, O. V.: Probing the volume changes during voltage gating of Porin 31BM channel with nonelectrolyte polymers. Biochimica et Biophysica Acta-Biomembranes 1612 (2), S. 144 - 153 (2003)

Döring, W. K.H.; Herzenstiel, M.-N.; Krampe, H.; Jahn, H.; Pralle, L.; Sieg, S.; Wegerle, E.; Poser, W.: Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics. Alcoholism: Clinical and Experimental Research 27, S. 849 - 861 (2003)

Ehrenreich, H.; Krampe, H.: Über den sozialpolitischen Umgang mit innovativen ambulanten Therapiekonzepten am Beispiel von ALITA - Behandeln oder nicht behandeln - das ist keine Frage! Zeitschrift für Allgemeine Medizin 79, S. 613 - 617 (2003)

Ehrenreich, H.; Sirén, A.-L.: EPO - Neuroprotektion bei Hirnerkrankungen. Georgia Augusta 2 (1), S. 111 - 115 (2003)

Fischer, A.; Sananbenesi, F.; Spiess, J.; Radulovic, J.: Cdk5 in the adult non-demented brain. Current Drug Targets 2 (6), S. 375 - 381 (2003)

Fischer, A.; Sananbenesi, F.; Spiess, J.; Radulovic, J.: Cdk5: A novel role in learning and memory. Neurosignals 12 (4-5), 10.1159/000074621, S. 200 - 208 (2003)